Your browser doesn't support javascript.
loading
Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.
Müller-Jensen, Leonie; Schulz, Axel R; Mei, Henrik E; Mohr, Raphael; Ulrich, Claas; Knape, Philipp; Frost, Nikolaj; Frischbutter, Stefan; Kunkel, Desiree; Schinke, Christian; Ginesta Roque, Lorena; Maierhof, Smilla K; Nickel, Florian T; Heinzerling, Lucie; Endres, Matthias; Boehmerle, Wolfgang; Huehnchen, Petra; Knauss, Samuel.
Affiliation
  • Müller-Jensen L; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Schulz AR; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Mei HE; Mass Cytometry Laboratory, German Rheumatism Research Center (DRFZ), A Leibniz Institute, Berlin, Germany.
  • Mohr R; Mass Cytometry Laboratory, German Rheumatism Research Center (DRFZ), A Leibniz Institute, Berlin, Germany.
  • Ulrich C; Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Knape P; Department of Dermatology, Venerology, and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Frost N; Collegium Medicum Berlin GmbH, Berlin, Germany.
  • Frischbutter S; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Kunkel D; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Schinke C; Institute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ginesta Roque L; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Maierhof SK; Flow and Mass Cytometry Core Facility, Berlin Institute of Health at Charité - Univeritätsmedizin Berlin, Berlin, Germany.
  • Nickel FT; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Heinzerling L; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Endres M; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Boehmerle W; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Huehnchen P; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Knauss S; Einstein Center for Neurosciences Berlin (ECN) at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Neuro Oncol ; 26(2): 279-294, 2024 02 02.
Article in En | MEDLINE | ID: mdl-37823709
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Neoplasms / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Neoplasms / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido